Woman walking a coastal bluff path at sunrise, illustrating brain health in midlife
Brain Health··6 min briefing

How Do You Actually Keep Your Brain Sharp?

Nothing is proven to prevent dementia. But 25 years of following nearly 8,000 people points at two dull habits, a 39-year Finnish study found the sauna advice everyone repeats has a temperature limit nobody mentions, and the one thing here with a real randomised trial behind it is the one nobody talks about.

Updated August 2026 · Reviewed by Roy Sañudo S.

How Do You Actually Keep Your Brain Sharp?

0:00 / 6 min briefing

Speed:
Read transcript

Key Takeaways

  • No single habit is proven to prevent dementia, and the strongest evidence belongs to the least exciting ones
  • Across nearly 8,000 people followed for 25 years, each point better on a heart-health score at 50 came with about 11% lower dementia risk, and sleeping six hours or less at 50 and at 60 came with a higher rate
  • In a 39-year Finnish study of 13,994 people, dementia risk was lowest around 80 to 99°C, and roughly doubled at 100°C or hotter in the first 20 years of follow-up
  • The famous finding that a year of exercise grows the hippocampus did not survive pooling eight later trials, and in the original trial the exercisers did not beat the stretching group on memory
  • Three randomised trials have now tested whether a NAD+ booster sharpens thinking in older adults with early memory trouble, and none of them beat placebo

You have started noticing it: the word that is right there and will not come, the reason you walked into the room, gone. That is not a dementia sign, and nothing here is proven to prevent dementia either. What 25 years of following nearly 8,000 people does show is that the habits with the strongest evidence are the dull ones, sleep and heart health in your forties and fifties.

What Has the Longest Evidence Behind It?

Sleep and blood pressure, by a distance.

Following nearly 8,000 British civil servants for 25 years, researchers at University College London and Inserm in Paris found that sleeping six hours or less at age 50 came with a higher rate of dementia, and again at 60. People short on sleep at all three check-ins, at 50, 60 and 70, had about 30% higher risk. That last number is the shakiest: the range around it runs from 1.00 to 1.69, and 1.00 would mean no effect at all, so it might be nothing.

Two limits. It watched people rather than testing anything, and the authors say short sleep may be an early sign the disease has already started rather than a cause. When a genetic study of 446,118 people went looking for cause, it found none, and the signal ran the other way: Alzheimer's risk predicted shorter sleep.

The same cohort scored heart health at 50 (smoking, diet, activity, weight, blood sugar, cholesterol, blood pressure) and followed people for 25 years. Each point better came with about 11% lower dementia risk. Same study design, so the same limit applies: watched, not tested. Not one habit, though. The stack. Our 2-minute vitality check covers the same ground.

Does a Sauna Really Lower Alzheimer's Risk?

The link is strong. The catch is the temperature.

A Finnish team at the University of Eastern Finland followed 2,315 men for a median of 20.7 years (Age and Ageing, 2017). Men using a sauna 4 to 7 times a week were about 65% less likely to be diagnosed with Alzheimer's than men who went once a week. The estimate is loose: the real effect could be small or large. And that study recorded only how often people went.

A second, much larger Finnish study looked at heat and time. Following 13,994 men and women for 39 years, it found the lowest dementia risk at around 80 to 99°C, though not clearly enough to be sure. What was clear: at 100°C and above, risk ran roughly double in the first 20 years, fading across the full 39. How long people stayed in barely mattered.

So: frequent and warm, not occasional and scorching, and both studies only watched people. Sauna is also not for everyone. Skip it with unstable chest pain, a recent heart attack, or severe narrowing of the aortic valve, the heart's main outflow valve, and never combine it with alcohol, which raises the risk of a dangerous blood-pressure drop, an irregular heartbeat, and sudden death.

Does Exercise Actually Grow Your Brain?

In a year-long trial of 120 older adults run at the University of Illinois, regular aerobic exercise grew the front of the hippocampus, the brain's memory centre, by about 2%, while a stretching group's shrank by about 1.4%. Two things have gone wrong with how that study gets retold.

We used to write that memory improved with it. The paper's own words: the exercise group *"did not improve performance above that achieved by the stretching control group."* Both groups improved by a similar amount. BDNF, the growth protein usually credited for this, did not rise more in the exercisers either.

The brain-growth part did not repeat. Pooling eight later trials in 554 people, researchers found no clear effect of exercise on hippocampal volume, and the 2011 study's own first author is a co-author on that null. The largest trial in this area, 1,635 adults over two years, found no overall cognitive benefit, though the oldest and frailest did improve on one measure.

Move anyway. Heart health at 50 is the strongest brain signal in this article, and exercise is how you move it. The hippocampus was never the point.

What About Your Hearing?

The one thing here that has been put to a proper randomised trial.

Hearing loss sits on the Lancet standing Commission's list of changeable things linked to dementia. In ACHIEVE, 977 adults aged 70 to 84 with untreated hearing loss were randomly given hearing aids or health education, then followed three years. Overall, both groups declined the same amount. But among those recruited from an older, higher-risk group, the hearing aids appeared to slow it.

The trial missed its main target and found a signal where risk was highest. That is still better evidence than anything else here, because somebody ran the experiment. If you are straining to follow conversations, get your hearing tested.

Can a Breathing Exercise Change Your Brain?

In one spot, in one trial, and it did not make anyone think better.

USC randomised 193 adults (2022). One group learned to breathe slowly at a pace tuned to their own heart rhythm; the other wore the same sensor but was coached to keep their heart rate flat. Five weeks later, of the 145 with usable scans, the first group had gained volume in one region behind the left eye and the second had lost it. That is two active groups compared with each other, and scan volume is not new brain cells.

The same team tested thinking, and working memory, processing speed and self-control were unchanged. No lab outside that team has repeated the brain finding in a peer-reviewed study. Slow breathing is free and safe, and we cover it in how to calm down in five minutes. Just do not expect a sharper memory.

What About Supplements and Cold Water?

NAD+ and NMN. NMN raises NAD+ in the blood easily. Whether that sharpens a brain has now been tested: three randomised trials gave older adults with early memory trouble a NAD+ booster for 8 to 12 weeks, and thinking scores did not beat placebo in any of them. The cleanest, with no industry funding, found the same nothing as the two with industry ties. A 2026 study of over 300 people also found blood NAD+ does not fall with age, which unsettles the premise under the whole category.

Vitamins. VITAL, run from Harvard, gave 2,000 IU of vitamin D daily to over 4,000 adults aged 60 and up: no slowing of decline, and no difference by starting vitamin D level. D-Health found the same nothing in 3,887 Australians on a monthly high dose. B vitamins are the one real exception: an Oxford trial of 271 people over 70 with mild memory problems slowed brain shrinkage, biggest in those who started high on homocysteine, a blood marker B vitamins bring down, though its lead author holds two university patents on that exact treatment. Oxford's own pooled analysis of 11 trials in 22,000 people found no effect on thinking. Fish oil: a Cochrane review found no benefit in healthy older adults, and the one clearly positive trial was in people already losing memory and moved one test out of several. Eat the fish. Skip the certainty.

Cold water. Cold exposure raises cold-shock proteins. Raising one in mice with Alzheimer-type and prion disease protected the connections between brain cells and lengthened survival (Nature, 2015, MRC Toxicology Unit at Leicester and Cambridge). Mice, and laboratory cooling: in humans that protein has only been measured in blood, in patients cooled by machines in hospital. Meanwhile 15 of 18 studies found being acutely cold makes people think *worse*. And sudden immersion can set off a dangerous heart rhythm even in healthy people. A lead for a future drug, not a reason to stand under cold water.

What to Do Tomorrow

Change nothing yet. Tomorrow night, write down when you got into bed and when you got up. Do that for a week, then subtract, and see what your real number is.

Sleep has the longest evidence here, and it is the habit people guess wrong about themselves. You cannot protect six hours you did not know you were missing. Here is how we check claims like these, and here is how I live with it.

Where the science stands

Our read after cross-checking every study and expert view.

Key findings

  • Moderate evidenceSleep and heart health in midlife carry the longest human evidence in this area, 25 years across nearly 8,000 people, but both are observational and a genetic study of 446,118 people found no causal link for sleep
  • Moderate evidenceFrequent sauna use tracks with much lower Alzheimer's risk, and a second, larger cohort found risk lowest around 80 to 99°C and roughly doubled above 100°C in the first 20 years
  • Strong evidenceRaising NAD+ does not sharpen thinking: three randomised trials in older adults with early memory trouble, all null, including one with no industry funding
  • Early signalA breathing practice changed the volume of one brain region in one trial, with no cognitive benefit and no independent replication

Where the research agrees

Independent groups in Finland, the United Kingdom, France, the United States and Australia converge on an uncomfortable pattern: the habits that show up strongest are sleep, blood pressure and the ordinary markers of heart health, measured over decades. They converge on the negative side too. Vitamin D, B vitamins and fish oil have each failed to improve cognition in large randomised trials, and NAD+ boosters have now failed the same test three times.

Where it's still debated

Whether any of it is causal. Almost every positive finding here comes from watching people rather than testing an intervention, and where researchers went looking for cause, in a Mendelian randomisation study of 446,118 people, they did not find it. Exercise is the sharpest example: a celebrated 2011 trial found hippocampal growth, and pooling eight later trials found no clear effect. Adult human neurogenesis is itself still contested, though a 2025 Karolinska Institute study identified dividing neural progenitor cells in the adult hippocampus.

Scientific References

This article synthesizes research from the following institutions and studies. All content is derived from peer-reviewed scientific literature and leading research centers.

USC Leonard Davis School of Gerontology (Dr. Mara Mather), HRV biofeedback and cortical volume. Funded by NIH R01AG057184; ClinicalTrials.gov NCT03458910.

Yoo et al., International Journal of Psychophysiology: "Heart rate variability (HRV) changes and cortical volume changes in a randomized trial of five weeks of daily HRV biofeedback in younger and older adults" (2022). PMID 36030986. DOI 10.1016/j.ijpsycho.2022.08.006. CORRECTED 2026-08-10 against the full text (PMC11195601): N=193 RANDOMISED (121 younger, 72 older), 162 completed all 7 weeks, 151 had both scans, N=145 in the ROI analysis — the old "N=162 enrolled" here was wrong. Left orbitofrontal cortex volume increased in the Osc+ arm relative to the Osc- arm, F(1,140)=8.33, p=.005 (Osc+ +0.55%, Osc- -0.96%); right OFC showed no effect, F(1,140)=1.36, p=.246. Pre-specified 2-ROI analysis, not a whole-brain search. ALSO CORRECTED: the old row said "the comparison group also did paced biofeedback" — it did NOT. Methods, verbatim: Osc- participants were "asked to come up with five strategies to lower heart rate and heart rate oscillations" and received an inverted "calmness" score; only the Osc+ arm used paced breathing at resonance frequency. It is still a between-arm difference, not absolute growth, and the paper does not use the word "neurogenesis". No independent lab has replicated it.

Nashiro et al., Applied Psychophysiology and Biofeedback: "Effects of a Randomised Trial of 5-Week Heart Rate Variability Biofeedback Intervention on Cognitive Function: Possible Benefits for Inhibitory Control" (2023). PMID 36030457. DOI 10.1007/s10484-022-09558-y. N=165. The primary result was NULL: the intervention did not significantly improve inhibitory control, working memory or processing speed. Only a secondary correlational analysis was positive, and the authors call for replication.

HeartMath Institute, emWave Pro biofeedback hardware and software — the instrument used to pace breathing and measure HRV in the USC trials above. HeartMath sells HRV devices; listed for provenance, not as independent evidence.

Laukkanen et al., Age and Ageing: "Sauna bathing is inversely associated with dementia and Alzheimer's disease in middle-aged Finnish men" (Dr. Jari Laukkanen, University of Eastern Finland, 2017). PMID 27932366. DOI 10.1093/ageing/afw212. Prospective cohort (KIHD), 2,315 men aged 42-60, median follow-up 20.7 years, 204 dementia and 123 Alzheimer cases. Alzheimer hazard ratio 0.35 (95% CI 0.14-0.90) for 4-7 sessions per week vs 1. Exposure recorded was FREQUENCY only; the study measured neither temperature nor session length.

Erickson et al., PNAS: "Exercise training increases size of hippocampus and improves memory" (run at the University of Illinois; first author then at Pittsburgh; 2011). PMID 21282661. DOI 10.1073/pnas.1015950108. Randomized trial, 120 older adults, 1 year; anterior hippocampal volume +2.12% left / +1.97% right vs -1.40%/-1.43% in stretching controls. CAUTION on the title: the paper's own Results state the exercise group "did not improve performance above that achieved by the stretching control group" on spatial memory (Time x Group F(1,102)=0.67, P<0.40), and serum BDNF did not rise more in exercisers (F(1,97)=1.42, P<0.23). Pooling 8 later trials in 554 people found no significant volume effect (PMID 37943486).

Dinoff et al., European Journal of Neuroscience: "The effect of acute exercise on blood concentrations of brain-derived neurotrophic factor in healthy adults: a meta-analysis" (2017). PMID 28493624. DOI 10.1111/ejn.13603. 55 studies; a single exercise session raised peripheral blood BDNF (SMD 0.59), with the effect present in men and not in women.

Singh-Manoux, Kivimaki et al., BMJ: "Timing of onset of cognitive decline: results from Whitehall II prospective cohort study" (2012). PMID 22223828. DOI 10.1136/bmj.d7622. University College London (Department of Epidemiology and Public Health) with a co-author at the University of Oxford Department of Psychiatry. 7,390 civil servants; reasoning scores already declining at ages 45-49.

Sabia, Kivimaki, Singh-Manoux et al., Nature Communications: "Association of sleep duration in middle and old age with incidence of dementia" (2021). PMID 33879784. DOI 10.1038/s41467-021-22354-2. University College London / Whitehall II. 7,959 participants, 25-year follow-up, 521 dementia cases; 6 hours or less at age 50 and 60 associated with higher dementia risk (HR 1.22 and 1.37); persistent short sleep about 30% higher risk. Observational.

Sabia, Ebmeier, Kivimaki, Singh-Manoux et al., BMJ: "Association of ideal cardiovascular health at age 50 with incidence of dementia: 25 year follow-up of Whitehall II cohort study" (2019). PMID 31391187. DOI 10.1136/bmj.l4414. University College London with a co-author at the University of Oxford Department of Psychiatry. 7,899 participants, 347 dementia cases; hazard ratio 0.89 per 1-point rise in the Life Simple 7 score. Observational.

Kang, Manson et al., Scientific Reports: "Effect of vitamin D on cognitive decline: results from two ancillary studies of the VITAL randomized trial" (Brigham and Women's Hospital / Harvard Medical School, 2021). PMID 34853363. DOI 10.1038/s41598-021-02485-8. 2,000 IU/day cholecalciferol, 4,218 participants aged 60+. No effect on cognitive decline (pooled mean difference 0.01, p=0.39) and NO interaction with baseline 25-hydroxyvitamin-D level.

Pham, Waterhouse, Neale et al., Journal of the American Geriatrics Society: "Vitamin D supplementation and cognition - Results from analyses of the D-Health trial" (QIMR Berghofer, 2023). PMID 36715270. DOI 10.1111/jgs.18247. 60,000 IU monthly for 5 years; cognition assessed in 3,887 participants aged 70+. No effect (mean difference 0.04; odds ratio for cognitive impairment 1.00).

Smith A.D. et al., PLoS ONE: "Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial" (VITACOG, Oxford Project to Investigate Memory and Ageing, University of Oxford, 2010). PMID 20838622. DOI 10.1371/journal.pone.0012244. n=271, 168 completed the MRI arm; whole-brain atrophy 0.76%/y on treatment vs 1.08% on placebo, with the benefit confined to participants with baseline homocysteine above ~11-13 umol/L. Declared conflict: A.D. Smith is named inventor on University of Oxford patents on this use and could benefit financially.

Clarke R. et al. (B-Vitamin Treatment Trialists' Collaboration), American Journal of Clinical Nutrition: "Effects of homocysteine lowering with B vitamins on cognitive aging: meta-analysis of 11 trials with cognitive data on 22,000 individuals" (Clinical Trial Service Unit, University of Oxford, 2014). PMID 24965307. DOI 10.3945/ajcn.113.076349. B vitamins lowered homocysteine by 26-28% and had no significant effect on any cognitive domain or on global cognition. Cite alongside VITACOG above; the two Oxford results are the honest pair.

Sydenham, Dangour & Lim, Cochrane Database of Systematic Reviews: "Omega 3 fatty acid for the prevention of cognitive decline and dementia" (2012). PMID 22696350. DOI 10.1002/14651858.CD005379.pub3. 3 trials, 3,536 participants at final follow-up; no benefit of omega-3 supplementation on cognitive function in cognitively healthy older people.

Knekt et al., Preventive Medicine Reports: "Does sauna bathing protect against dementia?" (Finnish Mobile Clinic Follow-up Survey, 2020). PMID 33088678. DOI 10.1016/j.pmedr.2020.101221. n=13,994 men AND women aged 30-69, 39-year follow-up, 1,805 dementia cases. THE DOSE STUDY: unlike PMID 27932366 it analysed temperature and session length against dementia. Verbatim: "The most favorable sauna temperature for dementia protection was 80-99 degrees C" (full-model HR 0.94, 0.85-1.04 vs under 80C, so not statistically clear) and "For high sauna temperatures of 100 degrees C or more, an elevated risk was revealed during the first 20 years (HR = 2.04, 95% CI = 1.32-3.15)", attenuating to 1.14 (0.92-1.43) across the full 39 years. Session length effectively null: 5-14 min HR 0.90 (0.80-1.01), 15+ min 0.87 (0.72-1.05). Frequency 9-12/month HR 0.81 (0.69-0.97). Observational. THIS CITATION FALSIFIED the article's previous claim, live in FAQPage JSON-LD since April, that no evidence-based sauna temperature or duration existed.

Livingston et al., The Lancet: "Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission" (2024). PMID 39096926. The standing list of modifiable dementia risk factors, including hearing loss. NOTE: cite for the existence and membership of the list. The population-attributable-fraction percentages have NOT been read off the paper here — read it before quoting one.

Lin et al., The Lancet: "Hearing intervention versus health education control to reduce cognitive decline in older adults with hearing loss in the USA (ACHIEVE): a multicentre, randomised controlled trial" (2023). PMID 37478886. n=977, aged 70-84, untreated hearing loss, 3-year follow-up. PRIMARY ENDPOINT NULL, verbatim: "The hearing intervention did not reduce 3-year cognitive decline in the primary analysis of the total cohort." A prespecified analysis found an effect in the higher-risk ARIC subpopulation but not the healthier de novo cohort. NEVER describe this as a positive trial without naming the null primary endpoint — an adversarial reviewer did exactly that on 2026-08-10.

Balbim, Erickson et al., GeroScience: "Aerobic exercise training effects on hippocampal volume in healthy older individuals: a meta-analysis of randomized controlled trials" (2024). PMID 37943486. 8 RCTs, n=554. NULL: SMD 0.10 (95% CI -0.01 to 0.21, p=0.073). "AET does not seem to impact hippocampal volume in cognitively unimpaired, healthy older individuals." Kirk Erickson, first author of the 2011 trial above, is a co-author on this null. Ship this beside PMID 21282661, never alone.

Sink, Espeland et al., JAMA: "Effect of a 24-Month Physical Activity Intervention vs Health Education on Cognitive Outcomes in Sedentary Older Adults: The LIFE Randomized Trial" (2015). PMID 26305648. n=1,635, aged 70-89. No difference in global or domain-specific cognition (Digit Symbol Coding mean difference -0.01, p=.97). BUT two prespecified subgroups DID improve on executive function: participants aged 80+ (n=307) and those with poorer baseline physical performance (n=328), both p=.01 for interaction. Do not write "no benefit at all" without that clause.

Martens et al., Alzheimer's & Dementia: "A phase-II randomized controlled pilot study of nicotinamide riboside supplementation in older adults with amnestic mild cognitive impairment" (2026). PMID 42478598. 12 weeks, null on cognitive function, NO declared conflicts of interest. Companion nulls WITH industry ties: PMID 37994989 (Orr 2024, ChromaDex-supplied drug, Brenner is ChromaDex CSO) and PMID 39817194 (Wu 2025, Tanzi holds ChromaDex equity). Three RCTs, three nulls — this is the MEASURED NULL that replaced the article's previous unfalsifiable "nobody has tested it".

Huang et al., Neurology: "Sleep, major depressive disorder, and Alzheimer disease: A Mendelian randomization study" (2020). PMID 32817390. Bidirectional 2-sample MR, UK Biobank n=446,118. NO causal effect of sleep traits on Alzheimer's; the signal ran the OTHER way (AD genetic risk predicted shorter sleep). Ship beside PMID 33879784 — it is the causal counterweight to the observational sleep-dementia association.

Peretti et al., Nature: "RBM3 mediates structural plasticity and protective effects of cooling in neurodegeneration" (2015). PMID 25607368. DOI 10.1038/nature14142. MRC Toxicology Unit, then at the University of Leicester; senior author Giovanna Mallucci also at the University of Cambridge. MOUSE study using laboratory cooling, not cold showers.

Curated by Roy Sañudo S.

Research Curator, Anima Cosmi

Anima Cosmi translates peer-reviewed research from Harvard, Oxford, Stanford, the Salk Institute, and other leading labs into plain language. Every article names its researchers, institutions, and publication years, so you can check the sources yourself.

Not medical advice. Anima Cosmi is a research curator, not a medical practice: this is education, not a prescription. Talk to a qualified healthcare provider before starting any new supplement, diet, or routine, especially if you take medication or have a health condition.


Continue Reading